Use of the Hepatitis B Virus Recombinant Baculovirus-HepG2 System to Study the Effects of (−)-Β-2′,3′-Dideoxy-3′-Thiacytidine on Replication of Hepatitis B Virus and Accumulation of Covalently Closed Circular DNA
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.43.8.2017
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 1999
Authors
Publisher
American Society for Microbiology